Skip to main content
. 2021 Apr 7;9:e11173. doi: 10.7717/peerj.11173

Table 4. Summary of findings including GRADE quality assessment for comparison between olive leaf extract and antihypertensive drugs.

No. of participants Anticipated absolute effects*
Outcomes No. of participants (studies) Captopril 12.5–25 mg Olive leaf extract 1000 mg per day MD 95% CI P-value Certainty of the evidence (GRADE) Comments
Systolic blood pressure (mmHg) 148 (1 RCT) 72 76 2.2 higher −0.43 to 4.83 0.10 ⊕⊕ LOWa,b Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa;
Diastolic blood pressure (mmHg) 148 (1 RCT) 72 76 1.6 higher −0.13 to 3.33 0.07 ⊕⊕ LOWa,b Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa;
Total cholesterol (mg/dl) 148 (1 RCT) 72 76 6.3 lower −12.75 to 0.15 0.06 ⊕⊕ LOWa,b Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa;
LDL (mg/dl) 148 (1 RCT) 72 76 6 lower −11.5 to -0.5 0.03 ⊕⊕ LOWa,b Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa;
HDL (mg/dl) 148 (1 RCT) 72 76 1 higher −0.79 to 2.79 0.27 ⊕⊕ LOWa,b Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa;
TG (mg/dl) 148 (1 RCT) 72 76 10.6 lower −25.04 to 3.84 0.15 ⊕⊕ LOWa,b Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa;
creatinine (mg/dl) 148 (1 RCT) 72 76 0.02 higher −0.03 to 0.07 0.45 ⊕⊕ LOWa,b Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa;
ALT (U/L) 148 (1 RCT) 72 76 1.1 higher −1.95 to 4.15 0.48 ⊕⊕ LOWa,b Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa;
AST (U/L) 148 (1 RCT) 72 76 1.9 higher 0.2 to 3.6 0.03 ⊕⊕ LOWa,b Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa;

Notes.

*

The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CI
Confidence interval
MD
Mean difference

Explanations

a

small population

b

wide CI

GRADE Working Group grades of evidence

High certainty: We are very confident that the true effect lies close to that of the estimate of the effect

Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different

Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect

Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect